These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 9731056)
21. Megakaryocytopoiesis in vitro: from the stem cells' perspective. Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217 [TBL] [Abstract][Full Text] [Related]
22. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Drexler HG; Quentmeier H Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457 [TBL] [Abstract][Full Text] [Related]
23. Human platelets display high-affinity receptors for thrombopoietin. Broudy VC; Lin NL; Sabath DF; Papayannopoulou T; Kaushansky K Blood; 1997 Mar; 89(6):1896-904. PubMed ID: 9058709 [TBL] [Abstract][Full Text] [Related]
24. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors. Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832 [TBL] [Abstract][Full Text] [Related]
25. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin. Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619 [TBL] [Abstract][Full Text] [Related]
26. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Debili N; Wendling F; Cosman D; Titeux M; Florindo C; Dusanter-Fourt I; Schooley K; Methia N; Charon M; Nador R Blood; 1995 Jan; 85(2):391-401. PubMed ID: 7529061 [TBL] [Abstract][Full Text] [Related]
27. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation. Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212 [TBL] [Abstract][Full Text] [Related]
28. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234 [TBL] [Abstract][Full Text] [Related]
29. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460 [TBL] [Abstract][Full Text] [Related]
30. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Hodohara K; Fujii N; Yamamoto N; Kaushansky K Blood; 2000 Feb; 95(3):769-75. PubMed ID: 10648384 [TBL] [Abstract][Full Text] [Related]
31. Effects of recombinant thrombopoietin on the growth of murine primitive and committed hematopoietic progenitors in serum-free culture. Sasaki H; Ikuta K; Funabiki T; Fujioka K; Matsuda M Pediatr Int; 1999 Dec; 41(6):666-72. PubMed ID: 10618888 [TBL] [Abstract][Full Text] [Related]
32. Thrombocytopenia in c-mpl-deficient mice. Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287 [TBL] [Abstract][Full Text] [Related]
33. Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice. Yan XQ; Lacey DL; Saris C; Mu S; Hill D; Hawley RG; Fletcher FA Exp Hematol; 1999 Sep; 27(9):1409-17. PubMed ID: 10480432 [TBL] [Abstract][Full Text] [Related]
34. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Methia N; Louache F; Vainchenker W; Wendling F Blood; 1993 Sep; 82(5):1395-401. PubMed ID: 7689867 [TBL] [Abstract][Full Text] [Related]
35. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818 [TBL] [Abstract][Full Text] [Related]
36. c-mpl, the thrombopoietin receptor. Vainchenker W; Methia N; Debili N; Titeux M; Wendling F Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519 [TBL] [Abstract][Full Text] [Related]
37. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines. Drexler HG; Quentmeier H Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663 [TBL] [Abstract][Full Text] [Related]
38. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation. Zweegman S; Veenhof MA; Huijgens PC; Schuurhuis GJ; Dräger AM Exp Hematol; 2000 Apr; 28(4):401-10. PubMed ID: 10781898 [TBL] [Abstract][Full Text] [Related]
39. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF). Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813 [TBL] [Abstract][Full Text] [Related]
40. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia. Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]